From the Practice

The Reassuring Number

October 22, 2026 6 min read By Naisohn Arfai, MD

Leonardo da Vinci drawing of the heart and coronary vessels

Leonardo da Vinci, The heart and coronary vessels, c. 1511 to 1513. Royal Collection.

A man in his late forties came to me having done, by any reasonable account, everything right. Over half a year he had changed how he ate, taken up strength training and cardio, and steadied his sleep and his family life. His cholesterol panel had improved, and his ApoB, the measure we watch most closely for cardiovascular risk, had fallen from 146 to 110 milligrams per deciliter. He had earned that result, and he was rightly proud of it.

Our work together began with a question about what that improved number might still be leaving out.

The number beneath the panel

A standard cholesterol panel reports how much cholesterol the blood is carrying. ApoB comes closer to the cause of the disease. Every particle capable of lodging in an artery wall, most of them LDL, carries a single ApoB protein, so measuring ApoB tells us how many of those particles are in circulation. Decades of genetic, population and clinical trial evidence point to the number of these particles, and the years the arteries are exposed to them, as the central driver of atherosclerosis.

By that measure his progress was real, and it was incomplete. A fall from 146 to 110 is a meaningful drop, and 110 still sits above the targets set by European cardiology guidelines, which call for an ApoB below 100 for people at moderate risk and below 80 for those at high risk. His advanced testing added detail. His LDL particle count was high, many of those particles were small and dense, and markers of inflammation in the vessel wall and of stress on the inner lining of his arteries were elevated. Together these told us that his risk had moved and remained present, and that the next stage of his plan would need to address it directly.

The finding that changed the plan

The result that reorganized his plan had nothing to do with cholesterol. We measured his cardiorespiratory fitness, his VO2 max, which reflects how much oxygen the body can take in and use during hard effort. His sat near the sixth percentile for men his age.

Cardiorespiratory fitness is among the strongest predictors we have of how long a person will live, and how well. In a study of more than 120,000 adults who completed treadmill testing at the Cleveland Clinic, those in the lowest fitness group had about five times the risk of death of the most fit over the years they were followed. The gap was comparable to, or larger than, the risk associated with smoking, diabetes or coronary artery disease. Fitness also responds to training at any age, and each step up from the lowest level is associated with lower risk.

Until we measured it, neither of us knew that his highest-leverage work lay in his capacity to move and to sustain effort. Once he could see it, the plan changed shape. Fitness moved to the center, his lipids and vascular markers were addressed alongside it, and we set dates to measure each again.

Measuring what matters

Precision medicine, as I have come to understand it, earns its name in a moment like this. Its purpose is to see a person clearly enough that the work he is already willing to do gets aimed at what will lengthen and improve his life. Some of the most useful measures, like fitness, take more effort to obtain, and they are often the ones that change a plan the most.

A good result deserves to be celebrated, and it can also open the next question. The one I keep returning to, with each person I care for, is a simple one. What are we not yet looking at?

Sources

Naisohn Arfai, MD

Physician-led longevity medicine

Learn more →

Continue reading

Interested in exploring whether HAYA Precision is right for you?